Home›Companies›Biotech & Pharma›DNA Seq 2

DNA Seq 2, Inc.

No website or LinkedIn page we could confirm. Why?
Updated Nov 11, 2026·Latest SEC filing Mar 11, 2026·Suggest an edit

About DNA Seq 2

DNA Seq 2 is a private company based in Vista, California, incorporated in 2022 in Delaware. It has reported $1,176,300 raised in one offering on Form D since March 2026. Its chief executive is Andrew Nappin.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Apr 10, 2024Mar 11, 2026$1,176,300fully sold32$36,759EquityRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on DNA Seq 2's Form D filed Mar 11, 2026.

Sources

  1. SECDNA SEQ 2, INC. filing history